Healthcare provider profile · identity verified

Robert Kaplan, MD

General Practice · CHICAGO, IL · NPI 1073561460

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	309	43
Atorvastatin Calcium	Atorvastatin Calcium	284	69
Gabapentin	Gabapentin	220	50
Amlodipine Besylate	Amlodipine Besylate	177	42
Spironolactone	Spironolactone	170	39
Alprazolam	Alprazolam	155	22
Losartan Potassium	Losartan Potassium	146	37
Prednisone	Prednisone	144	32
Metformin Hcl	Metformin Hcl	142	38
Albuterol Sulfate Hfa	Albuterol Sulfate	136	26
Levothyroxine Sodium	Levothyroxine Sodium	131	26
Tramadol Hcl	Tramadol Hcl	121	15
Furosemide	Furosemide	109	30
Metoprolol Succinate	Metoprolol Succinate	109	30
Montelukast Sodium	Montelukast Sodium	108	21
Jardiance	Empagliflozin	107	28
Promethazine Hcl	Promethazine Hcl	102	suppressed
Lisinopril	Lisinopril	101	29
Farxiga	Dapagliflozin Propanediol	100	21
Trazodone Hcl	Trazodone Hcl	96	25
Omeprazole	Omeprazole	85	19
Azithromycin	Azithromycin	79	34
Diclofenac Sodium	Diclofenac Sodium	78	12
Duloxetine Hcl	Duloxetine Hcl	78	19
Famotidine	Famotidine	78	19
Ozempic	Semaglutide	78	suppressed
Eliquis	Apixaban	76	23
Fluticasone Propionate	Fluticasone Propionate	75	17
Vascepa	Icosapent Ethyl	75	16
Allopurinol	Allopurinol	72	12
Carvedilol	Carvedilol	70	19
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	69	14
Pantoprazole Sodium	Pantoprazole Sodium	64	21
Quetiapine Fumarate	Quetiapine Fumarate	61	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	59	18
Topiramate	Topiramate	59	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	55	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	54	11
Diazepam	Diazepam	54	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	54	11
Hydralazine Hcl	Hydralazine Hcl	53	12
Torsemide	Torsemide	53	14
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	53	suppressed
Dexlansoprazole Dr	Dexlansoprazole	51	suppressed
Potassium Chloride	Potassium Chloride	51	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	50	suppressed
Ibuprofen	Ibuprofen	49	11
Meloxicam	Meloxicam	49	13
Tamsulosin Hcl	Tamsulosin Hcl	49	16
Mounjaro	Tirzepatide	48	suppressed
Meclizine Hcl	Meclizine Hcl	47	suppressed
Baclofen	Baclofen	45	16
Breo Ellipta	Fluticasone/Vilanterol	44	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	43	18
Ezetimibe	Ezetimibe	43	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	43	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	42	suppressed
Lorazepam	Lorazepam	40	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	40	25
Azelastine Hcl	Azelastine Hcl	39	suppressed
Ventolin Hfa	Albuterol Sulfate	38	11
Lidocaine	Lidocaine	37	suppressed
Sertraline Hcl	Sertraline Hcl	37	12
Trulicity	Dulaglutide	37	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	36	suppressed
Pregabalin	Pregabalin	36	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	34	suppressed
Mirtazapine	Mirtazapine	33	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	31	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	31	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	31	suppressed
Clopidogrel	Clopidogrel Bisulfate	29	suppressed
Ondansetron Hcl	Ondansetron Hcl	29	suppressed
Levetiracetam	Levetiracetam	27	suppressed
Clotrimazole	Clotrimazole	25	suppressed
Methotrexate	Methotrexate Sodium	25	suppressed
Pravastatin Sodium	Pravastatin Sodium	25	suppressed
Risperidone	Risperidone	25	suppressed
Cefdinir	Cefdinir	24	18
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	24	suppressed
Fluconazole	Fluconazole	24	11
Mupirocin	Mupirocin	24	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	24	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	23	suppressed
Loperamide	Loperamide Hcl	23	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	22	12
Esomeprazole Magnesium	Esomeprazole Magnesium	22	suppressed
Nifedipine Er	Nifedipine	22	suppressed
Simvastatin	Simvastatin	22	suppressed
Alcohol Pads	Alcohol Antiseptic Pads	21	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	21	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	21	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Benztropine Mesylate	Benztropine Mesylate	20	suppressed
Clonidine Hcl	Clonidine Hcl	20	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	20	suppressed
Naproxen	Naproxen	20	suppressed
Calcium Acetate	Calcium Acetate	19	suppressed
Icosapent Ethyl	Icosapent Ethyl	19	suppressed
Metolazone	Metolazone	19	suppressed
Midodrine Hcl	Midodrine Hcl	19	suppressed
Verapamil Er	Verapamil Hcl	19	suppressed
Ammonium Lactate	Ammonium Lactate	18	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	suppressed
Nitroglycerin	Nitroglycerin	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Clonazepam	Clonazepam	17	suppressed
Entresto	Sacubitril/Valsartan	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Lamotrigine	Lamotrigine	17	suppressed
Valsartan	Valsartan	17	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	16	suppressed
Fenofibrate	Fenofibrate,micronized	16	suppressed
Memantine Hcl	Memantine Hcl	16	suppressed
Fenofibrate	Fenofibrate	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Nebivolol Hcl	Nebivolol Hcl	15	suppressed
Novolog Flexpen	Insulin Aspart	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Acetazolamide	Acetazolamide	14	suppressed
Celecoxib	Celecoxib	14	suppressed
Divalproex Sodium	Divalproex Sodium	14	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	14	suppressed
Methadone Hcl	Methadone Hcl	14	suppressed
Metronidazole	Metronidazole	14	suppressed
Nyamyc	Nystatin	14	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	14	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Colchicine	Colchicine	13	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	13	suppressed
Desoximetasone	Desoximetasone	13	suppressed
Digoxin	Digoxin	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	12	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	12	suppressed
Creon	Lipase/Protease/Amylase	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Invokana	Canagliflozin	12	suppressed
Prazosin Hcl	Prazosin Hcl	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Candesartan-Hydrochlorothiazid	Candesartan/Hydrochlorothiazid	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Finasteride	Finasteride	11	suppressed
Linzess	Linaclotide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error